Farmacoriflessioni
Storia delle evidenze sull’uso pediatrico dei farmaci antiemetici
Evidence of the paediatric use of anti-emetics drugs: the history of domperidone
Federico Marchetti
UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
Giugno 2019 - pagg. 365 -369
Abstract
On 2nd May 2019 the Italian Medicines Agency (AIFA) issued an “Informative Note
agreed upon with the European Regulatory Authorities” on domperidone entitled Memorandum
on recommendations for minimising heart risks and eliminating prescriptions in
Paediatrics. The note was drafted in collaboration with the authorised pharmaceutical
companies that produce this drug. The present article reports the full note (because of its
informative nature) and comments its case that has been lasting for many years making
physicians think about the use of anti-emetics in Paediatrics both from a methodological
and practical perspective.
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. European Medicines Agency (EMA).
Coordination Group for Mutual Recognition
and Decentralised Procedures-Human
(CMDh). CMDh confirms recommendations
on restricting use of domperidone-containing
medicines. EMA 25-04-2014.
2. European Medicines Agency (EMA).
Pharmacovigilance Risk Assessment Committee
(PRAC). PRAC recommends restricting
use of domperidone. EMA/129231/
2014.
3. Marchetti F, Santuccio C; Gruppo di Lavoro
sui Farmaci Pediatrici AIFA. Il trattamento
farmacologico del vomito in etŕ pediatrica.
Bilancio tra rischi e benefici. AIFA, Bollettino
di Informazione sui Farmaci 2007;5:1-14.
4. AIFA. Segnalazioni di reazioni avverse a
PERIDON supposte nei bambini. Avviso
11/09/2007.
5. Albano F, Bruzzese E, Spagnuolo M, et al.
Antiemetics for children with gastroenteritis:
off label but still on in clinical practice. J Pediatr
Gastroenterol Nutr 2006;43:402-4.
6. Carter B, Fedorowicz Z. Antiemetic treatment
for acute gastroenteritis in children: an
updated Cochrane systematic review with
meta-analysis and mixed treatment comparison
in a Bayesian framework. BMJ Open
2012;2(4).
7. Scott B. Question 2. How effective is domperidone
at reducing symptoms of gastro-oesophageal
reflux in infants? Arch Dis Child
2012;97(8):752-5.
8. Murgia V, Marchetti F. Domperidone per
la nausea e il vomito: ancora un richiamo alla
limitazione d’uso per effetti collaterali (e
mancata dimostrazione di efficacia). Medico
e Bambino pagine elettroniche 2014;17(5).
9. Kita F, Hinotsu S, Yorifuji T, Urushihara
H, et al. Domperidone with ORT in the treatment
of pediatric acute gastroenteritis in Japan:
a multicenter, randomized controlled
trial. Asia Pac J Public Health 2015;27(2):
NP174-83.
10. Marchetti F, Bonati M, Maestro A, at al.
SONDO (Study ONdansetron vs DOmperidone)
Investigators. Oral ondansetron versus
domperidone for acute gastroenteritis in Pediatric
Emergency Departments: multicenter
double blind randomized controlled trial.
PLoS One 2016;11(11):e0165441.
11. Marchetti F, Bonati M, Maestro A, et al.
(a nome del Gruppo di Studio SONDO). La
reidratazione orale e l’uso dell’ondansetron e
del domperidone nella gastroenterite. Medico
e Bambino 2017;36(1):21-9.
12. Guarino A, Ashkenazi S, Gendrel D, et al
European Society for Pediatric Gastroenterology,
Hepatology, and Nutrition; European
Society for Pediatric Infectious Diseases. European
Society for Pediatric Gastroenterology,
Hepatology, and Nutrition/European
Society for Pediatric Infectious Diseases evidence-
based guidelines for the management
of acute gastroenteritis in children in Europe:
update 2014. J Pediatr Gastroenterol Nutr
2014;59(1):132-52.
13. Addis A. Traversa G. Trattamento del vomito
da gastroenterite: quando il bisogno clinico
chiama e la ricerca risponde. Medico e
Bambino 2017;36(1):7-9.
14. Marchetti F. Bambini e farmaci: da un
uso off-label a un uso consapevole e informativo.
Medico e Bambino 2014;33(7):415-6.
15. Yüksel K, Tuğlular I. Critical review of
European Medicines Agency (EMA) assessment
report and related literature on domperidone.
Int J Clin Pharm 2019 Mar 12.
16. Romano C, Dipasquale V, Scarpignato C.
Antiemetic drug use in children: what the clinician
needs to know. J Pediatr Gastroenterol
Nutr 2019;68(4):466-71.
Corrispondenza: federico.marchetti@auslromagna.it
